SCHEMBL7018102

SCHEMBL7018102

c1ccc2[nH]c(-n3ccnn3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.50
ACHE P22303 2/20 0.50
HTR3A P46098 1/20 0.49
EGLN1 Q9GZT9 1/20 0.48
TP53 P04637 3/20 0.47
RAB9A P51151 4/20 0.47
MAPT P10636 3/20 0.47
AURKA O14965 2/20 0.46
KDM4E B2RXH2 4/20 0.46
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 2/20 0.46
PKM P14618 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ABCB11 O95342 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TRPC3 Q13507 1/20 0.45
ALKBH3 Q96Q83 3/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451196 0.80 HTR3A (0.51) HTR3ARAB9AMAPTKDM4ENPC1
SCHEMBL546101 0.79 EGLN1 (0.51) BCHEACHEHTR3AEGLN1TP53
SCHEMBL3389271 0.78 BCHE (0.56) BCHEACHEHTR3ATP53RAB9A
SCHEMBL7027117 0.76 HTR3A (0.53) BCHEACHEHTR3AEGLN1TP53
SCHEMBL11030252 0.75 BCHE (0.49) BCHEACHEHTR3AEGLN1TP53
SCHEMBL861076 0.73 ALDH1A1 (0.49) BCHEACHEHTR3AEGLN1TP53
SCHEMBL9554794 0.73 BCHE (0.54) BCHEACHEHTR3AEGLN1TP53
SCHEMBL17054456 0.72 EGLN1 (0.51) BCHEACHEHTR3AEGLN1TP53
SCHEMBL4107024 0.71 BCHE (0.49) BCHEACHEHTR3ATP53RAB9A
SCHEMBL3591723 0.71 HTR3A (0.51) BCHEACHEHTR3AEGLN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1206260-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-10-30 EP disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
EP-1206260-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed
WO-2001000207-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed